Free Trial

Neo Ivy Capital Management Invests $716,000 in Equifax, Inc. (NYSE:EFX)

Equifax logo with Business Services background

Key Points

  • Neo Ivy Capital Management has acquired a new stake in Equifax, purchasing 2,940 shares valued at approximately $716,000 in the first quarter.
  • Several hedge funds have reported activities with Equifax shares, with institutional investors owning 96.20% of the company's stock.
  • Wall Street analysts have set a consensus rating of "Moderate Buy" for Equifax, with an average target price of $285.00, after various analysts adjusted their price targets downward.
  • MarketBeat previews top five stocks to own in September.

Neo Ivy Capital Management acquired a new stake in Equifax, Inc. (NYSE:EFX - Free Report) during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 2,940 shares of the credit services provider's stock, valued at approximately $716,000.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. True Wealth Design LLC grew its holdings in shares of Equifax by 1,920.0% during the 4th quarter. True Wealth Design LLC now owns 101 shares of the credit services provider's stock worth $26,000 after purchasing an additional 96 shares during the period. Ameriflex Group Inc. acquired a new stake in shares of Equifax during the fourth quarter valued at about $28,000. Colonial Trust Co SC raised its stake in shares of Equifax by 505.0% in the 4th quarter. Colonial Trust Co SC now owns 121 shares of the credit services provider's stock valued at $31,000 after acquiring an additional 101 shares during the period. City Holding Co. acquired a new stake in shares of Equifax during the first quarter worth about $34,000. Finally, ST Germain D J Co. Inc. purchased a new position in shares of Equifax in the first quarter valued at approximately $38,000. Institutional investors and hedge funds own 96.20% of the company's stock.

Equifax Stock Performance

Shares of Equifax stock traded down $2.72 on Wednesday, reaching $244.50. 152,812 shares of the stock were exchanged, compared to its average volume of 1,048,806. The company has a current ratio of 0.77, a quick ratio of 0.77 and a debt-to-equity ratio of 0.79. The firm has a market capitalization of $30.27 billion, a PE ratio of 47.85, a PEG ratio of 2.67 and a beta of 1.60. Equifax, Inc. has a 1-year low of $199.98 and a 1-year high of $309.63. The business has a fifty day moving average price of $259.90 and a two-hundred day moving average price of $253.09.

Equifax (NYSE:EFX - Get Free Report) last released its earnings results on Tuesday, July 22nd. The credit services provider reported $2.00 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.92 by $0.08. The company had revenue of $1.54 billion for the quarter, compared to analysts' expectations of $1.51 billion. Equifax had a return on equity of 18.89% and a net margin of 10.95%. The firm's quarterly revenue was up 7.4% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.82 EPS. As a group, research analysts anticipate that Equifax, Inc. will post 7.58 earnings per share for the current fiscal year.

Insider Transactions at Equifax

In other Equifax news, EVP John W. Gamble, Jr. sold 2,000 shares of the business's stock in a transaction on Tuesday, May 6th. The shares were sold at an average price of $259.10, for a total transaction of $518,200.00. Following the sale, the executive vice president directly owned 65,176 shares in the company, valued at approximately $16,887,101.60. The trade was a 2.98% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 1.40% of the company's stock.

Wall Street Analysts Forecast Growth

Several equities research analysts recently weighed in on EFX shares. Citigroup cut their target price on shares of Equifax from $294.00 to $290.00 and set a "buy" rating on the stock in a research note on Wednesday, July 23rd. Barclays reduced their price objective on Equifax from $260.00 to $240.00 and set an "equal weight" rating on the stock in a research note on Wednesday, July 23rd. BMO Capital Markets lowered their target price on Equifax from $280.00 to $260.00 and set a "market perform" rating for the company in a research note on Wednesday, July 23rd. Needham & Company LLC reissued a "buy" rating and issued a $295.00 target price on shares of Equifax in a report on Friday, June 20th. Finally, Bank of America downgraded Equifax from a "buy" rating to a "neutral" rating and dropped their price target for the stock from $300.00 to $285.00 in a research note on Monday, June 23rd. Seven investment analysts have rated the stock with a hold rating, twelve have given a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $285.00.

Get Our Latest Report on EFX

Equifax Profile

(Free Report)

Equifax Inc operates as a data, analytics, and technology company. The company operates through three segments: Workforce Solutions, U.S. Information Solutions (USIS), and International. The Workforce Solutions segment offers services that enables customers to verify income, employment, educational history, criminal justice data, healthcare professional licensure, and sanctions of people in the United States; and employer customers with services that assist them in complying with and automating payroll-related and human resource management processes throughout the entire cycle of the employment relationship.

Featured Articles

Institutional Ownership by Quarter for Equifax (NYSE:EFX)

Should You Invest $1,000 in Equifax Right Now?

Before you consider Equifax, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Equifax wasn't on the list.

While Equifax currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 Stocks to BUY NOW in August 2025
The $2.5B Merger No One Is Talking About
ALERT: Big Tech Earnings – Watch Before Wednesday

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines